Royal Orchid Hotels Limited has informed the Exchange about Transcript
ROHLTD · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Royal Orchid Hotels shared its Q4 FY25 and full-year results with analysts at a meet held at the newly launched ICONIQA Mumbai hotel. Q4 FY25 revenue rose 12% YoY to ₹92.34 crore with EBITDA up 7% at ₹25.52 crore. Full-year FY25 revenue grew 10% to ₹343 crore, EBITDA was ₹96.8 crore (up 2%), and PAT was ₹47.5 crore with EPS of ₹17.23. The company added 14 hotels (963 rooms) in FY25 and now operates 115 hotels with 9,583 keys across 78+ destinations. Management unveiled an ambitious 'Vision 2030' targeting 345 hotels, 20,000+ keys, ROCE of 25%+, and revenue of ₹550-600 crore within two years (up from ₹340 crore currently), based on its signed confirmed pipeline. ICONIQA Mumbai, the 292-room flagship hotel built in under 12 months, was showcased with an ADR target of around ₹9,000. The Regenta Rewards loyalty programme already has under 500,000 members showing 14-18% repeat usage.
Investors should note the bold long-term growth targets are based on the company's signed pipeline rather than speculation, which lends credibility. However, margins have been flat year-on-year due to post-COVID renovation costs, and the heavy branding and premiumisation push will require sustained investment. The greater visibility of the promoter family's next generation (Arjun and Keshav Baljee) suggests active succession planning, which could be positive for long-term governance.